(PSTI) = Up 44% for the week

patented technology to grow and expand adult Stem Cells

Adult stem cell development company commencing clinical trials applicable to estimated $30 billion degenerative disease market place

Reply New Message

Prev Message Back To Forum Threaded View Next Message

emit

Rank: Vice President [?]

Points: 41186 [?]

Votes: 199 Score: 3.0 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

(PSTI) = Up 44% for the week

posted on Mar 15, 2009 01:02PM

Stem Cell Stocks 3/14/09: The Week That Was

The stem cells stocks began the week with blaze, but ended rather anticlimactically with just a smolder. Most of the sector ended positive for the week, but most investors and/or stock traders were disappointed that gains from last Monday morning didn't hold.

Top Stem Cell Stock Performer(s) for Last Week:

- Pluristem Therapeutics (PSTI) = Up 44% for the week; This low floater is now getting a lift after the hangover from its secondary offering a little over a month ago.